Your Account
Sort
Categories
- #EMSPVirtual2021
- Associate members
- Document
- EMSP Events
- EMSP Events|EMSP News
- EMSP News
- EMSP News|From Europe
- EMSP News|From Europe|Stakeholder Events
- EMSP News|MS Research
- EMSP News|Press Releases
- EMSP News|Young People with MS
- From Europe
- From Europe|Member News
- From Europe|Stakeholder Events
- From Europe|Young People with MS
- Full members
- Full members|Member News
- Member News
- Member News|Young People with MS
- MS Research
- News – EMSP
- Press Releases
- Stakeholder Events
- Uncategorized
- Young People with MS
RiMS: Course on rehabilitation in multiple sclerosis
EMSP’s partners from Rehabilitation in MS (RiMS) are endorsing a residential course on rehabilitation in multiple sclerosis (MS) which will…
RiMS: Course on rehabilitation in multiple sclerosis
EMSP’s partners from Rehabilitation in MS (RiMS) are endorsing a residential course on rehabilitation in multiple sclerosis (MS) which will…
IMPRESS study: Focus on people with MS and their carers
The London School of Economics (LSE) is currently leading a study – IMPRESS – which explores the social economic costs, quality of life and…
EMA and EUnetHTA release joint report on medicines data
The European Medicines Agency (EMA) and the European Network for Health Technology Assessment (EUnetHTA) have published a report on their…
EMA to bolster support for medicines targeting unmet medical needs
The European Medicines Agency (EMA) has launched, on 7 March, a scheme designed to strengthen support to medicines that target an…
EMA to bolster support for medicines targeting unmet medical needs
The European Medicines Agency (EMA) has launched, on 7 March, a scheme designed to strengthen support to medicines that target an unmet medical need – EMA Prime.
